Literature DB >> 9242780

Localization of language cortices by functional MR imaging compared with intracarotid amobarbital hemispheric sedation.

M M Bahn1, W Lin, D L Silbergeld, J W Miller, K Kuppusamy, R J Cook, G Hammer, R Wetzel, D Cross.   

Abstract

OBJECTIVE: We undertook this study to investigate functional MR imaging as a new clinical method for determining hemispheric language dominance. Seven patients undergoing surgical evaluation for chronic intractable epilepsy were studied. Intracarotid amobarbital injection was also performed and the findings compared with the functional MR imaging results.
CONCLUSION: Functional MR imaging studies enabled localization of the frontal and temporal lobe language cortices. The results of functional MR imaging and intracarotid amobarbital testing of hemispheric language dominance agreed in all seven patients, including two right-handed patients with right-hemisphere language dominance. These preliminary results show that functional MR imaging is an accurate noninvasive method of determining language dominance that may replace the amobarbital test for some purposes if confirmed by additional research.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242780     DOI: 10.2214/ajr.169.2.9242780

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

Review 1.  Functional magnetic resonance imaging: clinical applications and potential.

Authors:  P M Matthews; S Clare; J Adcock
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Method for quantitatively evaluating the lateralization of linguistic function using functional MR imaging.

Authors:  S I Nagata; K Uchimura; W Hirakawa; J I Kuratsu
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

3.  Developmental aspects of language processing: fMRI of verbal fluency in children and adults.

Authors:  William D Gaillard; Bonnie C Sachs; Joseph R Whitnah; Zaaira Ahmad; Lyn M Balsamo; Jeffrey R Petrella; Suzanne H Braniecki; Christopher M McKinney; Kevin Hunter; Ben Xu; Cecile B Grandin
Journal:  Hum Brain Mapp       Date:  2003-03       Impact factor: 5.038

4.  MRI language dominance assessment in epilepsy patients at 1.0 T: region of interest analysis and comparison with intracarotid amytal testing.

Authors:  K Deblaere; P A Boon; P Vandemaele; A Tieleman; K Vonck; G Vingerhoets; W Backes; L Defreyne; E Achten
Journal:  Neuroradiology       Date:  2004-05-01       Impact factor: 2.804

Review 5.  Neuroimaging correlates of language network impairment and reorganization in temporal lobe epilepsy.

Authors:  S Balter; G Lin; K M Leyden; B M Paul; C R McDonald
Journal:  Brain Lang       Date:  2016-07-05       Impact factor: 2.381

6.  Language network measures at rest indicate individual differences in naming decline after anterior temporal lobe resection.

Authors:  Samantha Audrain; Alexander J Barnett; Mary P McAndrews
Journal:  Hum Brain Mapp       Date:  2018-06-28       Impact factor: 5.038

Review 7.  [Clinical application of functional MRI for chronic epilepsy].

Authors:  F G Woermann; K Labudda
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

8.  Effect of handedness on fMRI activation in the medial temporal lobe during an auditory verbal memory task.

Authors:  Jennifer L Cuzzocreo; Michael A Yassa; Guillermo Verduzco; Nancy A Honeycutt; David J Scott; Susan Spear Bassett
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

9.  Sensitivity and reliability of language laterality assessment with a free reversed association task--a fMRI study.

Authors:  Gunther Fesl; Philipp Bruhns; Sabine Rau; Martin Wiesmann; Josef Ilmberger; Gerd Kegel; Hartmut Brueckmann
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

10.  The evolution of clinical functional imaging during the past 2 decades and its current impact on neurosurgical planning.

Authors:  J J Pillai
Journal:  AJNR Am J Neuroradiol       Date:  2010-02       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.